Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...
Tiger BioSciences, a leader in regenerative medicine and tissue innovation, today announced the acquisition of Platelet-Rich ...
2don MSN
Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics
Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...
On Monday, Microchip said it now expects third-quarter fiscal 2026 net sales of approximately $1.185 billion for the period ...
Cogent Biosciences Inc. (NASDAQ: COGT) is one of the best emerging technology stocks to invest in. On December 19, JPMorgan ...
Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
UKRI Innovate UK and NRC IRAP provide funding and advisory support, fostering UK-Canada collaboration in genetic medicine ...
In 2025, Tiger BioSciences supported and generated five peer‑reviewed retrospective clinical studies, two of which focused on ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ:PLSE), a medical device company with a market capitalization of $966 million trading at $14.26 per share, announced Thursday that the U.S. Food and ...
Rather than yeast or microalgae, the company is working with oleaginous bacteria—which it claims are more productive.
Investing.com -- Skye Bioscience Inc (NASDAQ:SKYE) stock jumped 5.3% in premarket trading Monday after the company announced a collaboration with Halozyme Therapeutics (NASDAQ:HALO) to develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback